- Home
- KIDS vs ARCT Comparison
KIDS vs ARCT Comparison
Compare KIDS & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIDS
- ARCT
- Stock Information
- Founded
- KIDS 2007
- ARCT 2013
- Country
- KIDS United States
- ARCT United States
- Employees
- KIDS N/A
- ARCT N/A
- Industry
- KIDS Medical/Dental Instruments
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- KIDS Health Care
- ARCT Health Care
- Exchange
- KIDS Nasdaq
- ARCT Nasdaq
- Market Cap
- KIDS 662.5M
- ARCT 602.7M
- IPO Year
- KIDS 2017
- ARCT N/A
- Fundamental
- Price
- KIDS $22.93
- ARCT $16.02
- Analyst Decision
- KIDS Buy
- ARCT Strong Buy
- Analyst Count
- KIDS 7
- ARCT 7
- Target Price
- KIDS $37.14
- ARCT $65.00
- AVG Volume (30 Days)
- KIDS 169.5K
- ARCT 400.2K
- Earning Date
- KIDS 11-06-2024
- ARCT 11-07-2024
- Dividend Yield
- KIDS N/A
- ARCT N/A
- EPS Growth
- KIDS N/A
- ARCT N/A
- EPS
- KIDS N/A
- ARCT N/A
- Revenue
- KIDS $189,673,000.00
- ARCT $160,399,000.00
- Revenue This Year
- KIDS $38.72
- ARCT $13.02
- Revenue Next Year
- KIDS $18.68
- ARCT $5.58
- P/E Ratio
- KIDS N/A
- ARCT N/A
- Revenue Growth
- KIDS 33.47
- ARCT N/A
- 52 Week Low
- KIDS $22.41
- ARCT $14.93
- 52 Week High
- KIDS $36.23
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- KIDS 35.90
- ARCT 31.24
- Support Level
- KIDS $23.77
- ARCT $18.90
- Resistance Level
- KIDS $32.00
- ARCT $21.61
- Average True Range (ATR)
- KIDS 1.72
- ARCT 1.15
- MACD
- KIDS -0.51
- ARCT -0.07
- Stochastic Oscillator
- KIDS 5.42
- ARCT 16.32
About KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.